Understanding GLP-1 peptides like Semaglutide and Tirzepatide - how they work, their effectiveness, and what the research shows for weight management.
GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a class of peptides that mimic a natural hormone your body produces after eating.
Signals the brain to feel full, reducing hunger and food cravings
Food stays in stomach longer, prolonging satiety
Improves blood sugar control, reducing fat storage
Lessens the pleasure response to high-calorie foods
Semaglutide is a GLP-1 receptor agonist approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). It has become one of the most prescribed weight loss medications.
| Weeks | Dose | Purpose |
|---|---|---|
| 1-4 | 0.25mg weekly | Initiation |
| 5-8 | 0.5mg weekly | Titration |
| 9-12 | 1.0mg weekly | Titration |
| 13-16 | 1.7mg weekly | Titration |
| 17+ | 2.4mg weekly | Maintenance |
Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates two incretin pathways simultaneously. This dual mechanism appears to produce superior weight loss results.
| Weeks | Dose |
|---|---|
| 1-4 | 2.5mg weekly |
| 5-8 | 5mg weekly |
| 9-12 | 7.5mg weekly |
| 13-16 | 10mg weekly |
| 17+ | 12.5-15mg weekly (max) |
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 only | GLP-1 + GIP (dual) |
| Average Weight Loss | 15-17% | 20-22% |
| Max Dose | 2.4mg weekly | 15mg weekly |
| Brand Names | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
| FDA Weight Loss Approval | Yes (Wegovy) | Yes (Zepbound) |
| Oral Option | Yes (Rybelsus) | In development |
Earlier GLP-1 agonist, daily injection. Average 8% weight loss. More side effects than newer options but well-established safety profile.
Fragment of human growth hormone (HGH). Researched for fat metabolism without GH's muscle-building effects. Limited human data.
Mitochondrial-derived peptide that regulates metabolism. Early research shows effects on insulin sensitivity and fat oxidation.
GHRH analog approved for HIV-associated lipodystrophy. Reduces visceral fat. Not approved for general weight loss.
GLP-1 medications require a prescription and medical supervision. They are not appropriate for everyone. Consult with a healthcare provider to determine if these medications are right for you.
Disclaimer: This content is for educational purposes only and is not medical advice. GLP-1 medications are prescription drugs with potential serious side effects. Always consult a qualified healthcare provider before starting any weight loss medication.